See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case 3: My Own Complex Retrograde Approach

Presenter: Etsuo Tsuchikane

October 25, 2012

Presentation TCT 2012

Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter?

Presenter: C. Michael Gibson

October 25, 2012

Presentation TCT 2012

Primary PCI: Current Procedural Controversies and Decision-Making

Presenter: Michel Le May

October 25, 2012

Presentation TCT 2012

Beyond OFDI: Next-Generation OCT Systems

Presenter: Brett Bouma

October 25, 2012

Presentation TCT 2012

New VH-IVUS Insights from PROSPECT and HORIZONS-AMI

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Carotid Intervention in a Complex Aortic Arch

Presenter: Felix Damas de los Santos

October 25, 2012

Presentation TCT 2012

Endovascular, Hybrid, and Open Approaches: Decision-making in Paravisceral and Thoracoabdominal Aneurysms

Presenter: Joseph Ricotta II

October 25, 2012

Presentation TCT 2012

Part 2: Will the Transcatheter Valve Therapy Registry Transform US Regulatory Strategies?

Presenter: David Holmes Jr

October 25, 2012

Presentation TCT 2012

TAVR in a Patient with Severely Depressed Left Ventricular Ejection Fraction

Presenter: Ariel Roguin

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Advertisement

Slides

Case 3: My Own Complex Retrograde Approach

Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter?

Primary PCI: Current Procedural Controversies and Decision-Making

Beyond OFDI: Next-Generation OCT Systems

New VH-IVUS Insights from PROSPECT and HORIZONS-AMI

Carotid Intervention in a Complex Aortic Arch

Endovascular, Hybrid, and Open Approaches: Decision-making in Paravisceral and Thoracoabdominal Aneurysms

Part 2: Will the Transcatheter Valve Therapy Registry Transform US Regulatory Strategies?

TAVR in a Patient with Severely Depressed Left Ventricular Ejection Fraction

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content